The Fourth Annual TPT® Conference will be held February 18, 2022 at the Hilton Knoxville Airport.
Visit http://gsm.utmck.edu/cme/courses/TargetedPain/main.cfm, for more information and to register.
Targeted Pain Treatment® is a federally registered trademark owned by Dr. Stephanie Vanterpool. Dr. Vanterpool developed and is responsible for the content contained in the TPT Toolkit.
Targeted pain treatment is the process of accurately diagnosing the underlying cause of pain, and the targeting the treatment to the cause of pain. The goal is to effectively treat pain and improve function, while also reducing unnecessary opioid medication use.
Targeted Pain Treatment differs from other approaches to pain management by seeking to treat the true cause of pain, rather than focusing on lowering a patient's pain score.
Purpose of the TPT Toolkit is to provide tools and information needed to help clinicians implement targeted pain treatment in their practices. These include decision aids, references, and other useful resources as developed and collated. The TPT Toolkit contains downloadable tools, templates and decision aids to help you practice Targeted Pain Treatment, access to 2019 Conference speaker talks, and infographics.
To access the TPT Toolkit, please click here: TPT Toolkit Download (Your email address is required)
Tennessee Chronic Pain Guidelines (3rd Edition)
Vanterpool SG. Targeted pain treatment - Reduce opioids, reclaim relief. Journal of the Tennessee Medical Association. 2018 Mar;110(4):9-10.
Please note: Targeted Pain Treatment® is a federally registered trademark owned by Dr. Stephanie Vanterpool. Dr. Vanterpool developed and is responsible for the content contained in the TPT Toolkit.
Download Infographics (email address required)
The University of Tennessee Graduate School of Medicine
1924 Alcoa Highway
Knoxville, Tennessee 37920 | 865-305-9290
Copyright © 2019